Taipei Exchange - Delayed Quote TWD

Lukas Biomedical Inc. (6814.TWO)

Compare
24.60
-0.10
(-0.40%)
At close: 9:35:46 AM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Chaoan Liu Manager -- -- --
Yingmin Liu Accounting Supervisor -- -- --

Lukas Biomedical Inc.

No. 14-16, Zhongxiao Road
1st Floor Banqiao District
New Taipei City, 220
Taiwan
886 2 2950 0027 https://lukas-bio.com.tw
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
88

Description

Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. It operates through E-Commerce, Medical Management Business, Cell Products, and Pharmaceutical Market Development segments. The company also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases housing equipment. In addition, the company offers cell reagents; and brand management and consulting services. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei City, Taiwan.

Corporate Governance

Lukas Biomedical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers